No Data
The Market Doesn't Like What It Sees From Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Revenues Yet As Shares Tumble 30%
Unfortunately for some shareholders, the Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) share price has dived 30% in the last thirty days, prolonging recent pain. The recent drop completes a
Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors
Avacta Group plc Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors London, England; July 8, 2024; Avacta Group plc (AIM: AVCT), a life sciences company
Pieris Pharmaceuticals Faces Agreement Termination and Pursues New Opportunities
Express News | Pieris Pharmaceuticals- Company Does Not Intend to Pursue Any Further Development of S095012
Express News | Pieris Pharmaceuticals- Servier's Decision to Terminate Agreements Was Based on a Potential Safety Concern in S095012 Phase 1 Clinical Studies
Express News | Pieris Pharmaceuticals- With Notice, Servier Will Discontinue and Cease Dosing in the Phase 1 Clinical Study of S095012
TrytosaveabitOP : Pieris Pharmaceuticals- Servier's Decision to Terminate Agreements Was Based on a Potential Safety Concern in S095012 Phase 1 Clinical Studies